Drugs / Expanded adipose-derived stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01808378 | Feb → Dec 2013 | keratopathy | Instituto de Investigación Hospital Universitario La Paz | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Expanded adipose-derived stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01808378 ↗ |
| Modality | Cell therapy | “human autologous adipose tissue-derived adult mesenchymal stem cells (ASCs)” PMID 38152876 ↗ Dec 2023 |
| Route | Other | “400,000 ASCs were injected into each limboconjunctival quadrant” PMID 38152876 ↗ Dec 2023 |